Jupiter Neurosciences, Correlations
| JUNS Stock | USD 9.73 1.13 10.41% |
The current 90-days correlation between Jupiter Neurosciences, and Dogwood Therapeutics, is -0.04 (i.e., Good diversification). The correlation of Jupiter Neurosciences, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Jupiter Neurosciences, Correlation With Market
Good diversification
The correlation between Jupiter Neurosciences, Common and DJI is -0.19 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Jupiter Neurosciences, Common and DJI in the same portfolio, assuming nothing else is changed.
Jupiter |
Related Correlations Analysis
| -0.61 | -0.64 | 0.72 | 0.09 | DWTX | ||
| -0.61 | 0.7 | -0.66 | -0.01 | EPRX | ||
| -0.64 | 0.7 | -0.56 | -0.16 | CEROW | ||
| 0.72 | -0.66 | -0.56 | 0.14 | IRD | ||
| 0.09 | -0.01 | -0.16 | 0.14 | TLX | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Jupiter Stock performing well and Jupiter Neurosciences, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Jupiter Neurosciences,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DWTX | 7.67 | (0.52) | 0.00 | (0.70) | 0.00 | 15.01 | 69.76 | |||
| EPRX | 3.66 | 0.23 | 0.05 | (0.49) | 3.86 | 10.43 | 34.56 | |||
| CEROW | 26.34 | 5.11 | 0.20 | (1.73) | 22.06 | 66.67 | 191.74 | |||
| IRD | 3.86 | (0.52) | 0.00 | (0.19) | 0.00 | 8.91 | 29.54 | |||
| TLX | 1.67 | 0.18 | 0.07 | (0.94) | 1.72 | 4.38 | 10.19 |
Jupiter Neurosciences, Corporate Executives
Elected by the shareholders, the Jupiter Neurosciences,'s board of directors comprises two types of representatives: Jupiter Neurosciences, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jupiter. The board's role is to monitor Jupiter Neurosciences,'s management team and ensure that shareholders' interests are well served. Jupiter Neurosciences,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jupiter Neurosciences,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marshall Hayward | Chief CoFounder | Profile | |
| Shaun Brothers | Consulting CoFounder | Profile | |
| Alexander Rosen | CoFounder Officer | Profile | |
| Saleem CPA | CFO Secretary | Profile |